High-Concentration, Low-Volume Subcutaneous Formulation

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Jay Wealand

Jay Wealand is a principal scientist at Pfizer BioTherapeutics Research and Development

Articles by Jay Wealand

Advances in Monoclonal Antibody Purification

ByJay Wealand,Brian Chen,Erin Miller-Cary,Denis Boyle, PhD,Judy Glynn,Paul Mensah, PhD

March 2nd 2010

New technologies and adaptations of existing technologies can improve platform processes.

Latest Updated Articles

Advances in Monoclonal Antibody Purification
March 2nd 2010